Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0RQVGN)
| ADC Name |
Enoblituzumab-ADC-24-13
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Enoblituzumab ADC 24 13
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4-8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Enoblituzumab
|
Antibody Info | ||||
| Antigen Name |
CD276 antigen (CD276)
|
Antigen Info | ||||
| Payload Name |
Enoblituzumab-ADC-24-13 payload
|
|||||
| Linker Name |
Enoblituzumab-ADC-24-13 linker
|
|||||